Market Tracker

06/27 12:48pm ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

8.18
Delayed Data
As of 12:33pm ET
 -0.17 / -2.04%
Today’s Change
4.20
Today|||52-Week Range
10.55
+5.41%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close8.35
Today’s open8.26
Day’s range7.82 - 8.31
Volume92,201
Average volume (3 months)199,748
Market cap$357.3M
Dividend yield--
Data as of 12:33pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-23.29%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+28.82%
P/E ratioNM
Price/Sales8.30
Price/Book7.31

Competitors

 Today’s
change
Today’s
% change
PTIProteostasis Therape...-2.33-15.26%
NVTAInvitae Corp-0.50-5.88%
RDNTRadNet Inc-0.04-0.78%
CCMConcord Medical Serv...-0.08-2.13%
Data as of 12:43pm ET, 06/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$39.4M
Annual profit (last year)-$42.2M
Net profit margin-107.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts